Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary

This paper analyzes pricing strategies for US pediatric combination vaccines by comparing the lowest overall cost formularies (i.e., formularies that have the lowest overall cost). Three pharmaceutical companies compete pairwise over the sale of monovalent and combination vaccines. Particular emphasis is placed on examining the price of Sanofi Pasteur’s DTaP-IPV/HIb under different conditions. The main contribution of the paper is to provide the lowest overall cost formularies for different prices of DTaP-IPV/HIb and other Sanofi Pasteur vaccines. The resulting analysis shows that DTaP-IPV/HIb could have been more competitively priced compared with the combination vaccine DTaP-HepB-IPV, for federal contract prices in 2009, 2010 and 2011. This study also proposes the lowest overall cost formularies when shortages of monovalent vaccines occur.

[1]  Robert T. Chen,et al.  Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. , 1998, Vaccine.

[2]  Sheldon H Jacobson,et al.  Stockpile levels for pediatric vaccines: how much is enough? , 2006, Vaccine.

[3]  Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose. , 2008, MMWR. Morbidity and mortality weekly report.

[4]  Sheldon H. Jacobson,et al.  Engineering the Economic Value of Two Pediatric Combination Vaccines , 2005, Health care management science.

[5]  Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months. , 2009, MMWR. Morbidity and mortality weekly report.

[6]  S H Jacobson,et al.  “Reverse engineering” a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines , 2001, The Pediatric infectious disease journal.

[7]  S H Jacobson,et al.  An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study , 1999, Health care management science.

[8]  Sarah J Clark,et al.  Variation in Provider Vaccine Purchase Prices and Payer Reimbursement , 2008, Pediatrics.

[9]  S. Dowell,et al.  Recommended childhood immunization schedule-United States, January-December 2001. Committee on Infectious Diseases. , 2001, Pediatrics.

[10]  S. Chu,et al.  Factors affecting U.S. manufacturers' decisions to produce vaccines. , 2005, Health affairs.

[11]  Matthew J. Robbins,et al.  Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix® or Pentacel®? , 2010, Health care management science.

[12]  A. Cowan,et al.  Variation in Provider Vaccine Purchase Prices and Payer Reimbursement , 2008, Pediatrics.

[13]  Sheldon H. Jacobson,et al.  Using an Integer Programming Model to Determine the Price of Combination Vaccines for Childhood Immunization , 2003, Annals of Operations Research.

[14]  Sheldon Howard Jacobson,et al.  Pediatric vaccine procurement policy: The monopsonist's problem , 2011 .